# Emory Training Program in Translational Research to End the HIV Epidemic

> **NIH NIH T32** · EMORY UNIVERSITY · 2022 · $491,488

## Abstract

Project Abstract
In this application entitled `Emory Training Program in Translational Research to End the HIV Epidemic',
we propose a new T32 training program focused on translational HIV science located at the epicenter of the
US HIV epidemic in the Southern US at Emory University in Atlanta, GA. Our training program will provide 2
years of support to 5 post-doctoral fellows and a summer internship opportunity for 2 pre-doctoral under-
represented minority (URM) students to conduct cutting-edge HIV research through hands-on experience and
formal didactics and also educate trainees on the broader context of HIV research across the translational
continuum. Our training program will be fully integrated with and capitalize on the significant HIV research
portfolio of the Emory Center for AIDS Research (CFAR) and span the spectrum of ongoing HIV research
activities in 3 major areas of focus: 1. Laboratory-based basic science, vaccine, and cure research, 2.
Patient-centered clinical research, and 3. Public health and implementation science. Our training
program will encompass research activities in each of the NIH HIV/AIDS research priorities to reduce the
incidence of HIV, develop next generation HIV therapeutics, conduct research towards an HIV cure, and
address HIV associated co-morbidities, co-infections and complications; but, more importantly, our program
will also expose trainees to cross-cutting areas of HIV research and team science to accelerate the translation
of discovery into improved health outcomes. We have assembled a team of 35 diverse and experienced
mentors across the 3 HIV research focus areas and designed didactic opportunities for our mentees to
complement their research projects and expand their understanding of bench to bedside to community
translation of HIV research innovation. In addition, the geographic position of our training program located in
and surrounded by 4 of the counties named as focus areas for the Department of Health and Human Services
Ending the HIV Epidemic (EHE) initiative further demonstrates the urgency to develop and support the next
generation of HIV investigators specifically at our institution. Given the gravity of the HIV epidemic in the South
and globally and the new DHHS initiative that proposes to end the US HIV epidemic in the next 10 years,
fostering the next generation of translational HIV scientists across the HIV research continuum is of utmost
importance. Post-doctoral trainees will emerge from our T32 program ready for scientific independence and
with a deep understanding of how their research fits into the multidirectional and multidisciplinary framework of
HIV research with the long-term goal of ending the HIV epidemic.

## Key facts

- **NIH application ID:** 10475304
- **Project number:** 5T32AI157855-02
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Ann M Chahroudi
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $491,488
- **Award type:** 5
- **Project period:** 2021-08-25 → 2026-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10475304

## Citation

> US National Institutes of Health, RePORTER application 10475304, Emory Training Program in Translational Research to End the HIV Epidemic (5T32AI157855-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10475304. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*